DOI QR코드

DOI QR Code

Clinicopathological Features of Colon Adenocarcinoma in Qazvin, Iran: A 16 Year Study

  • Hajmanoochehri, Fatemeh (Department of Pathology, Metabolic Diseases Research Center, Qazvin University of Medical Sciences) ;
  • Asefzadeh, Saeed (Department of Health Care Management, Metabolic Diseases Research Center, Qazvin University of Medical Sciences) ;
  • Kazemifar, Amir Mohammad (Forensic Medicine, Metabolic Diseases Research Center, Qazvin University of Medical Sciences) ;
  • Ebtehaj, Mehdi (Department of Anesthesiology, Metabolic Diseases Research Center, Qazvin University of Medical Sciences)
  • Published : 2014.01.30

Abstract

Background: Colorectal cancer (CRC) was the fourth most commonly diagnosed cancer in Iran between 2000 and 2009, with adenocarcinoma (AC) as the most common histological type. Demographic, topographic and histological variables are important in the epidemiology and biology of cancer. The aim of this study was to investigate clinicopathological features of colon adenocarcinomas in Qazvin, Iran. Materials and Methods: With a retrospective design, patient records of two pathology wards from March 1997 to March 2013 were studied with regard to anatomical location and histological classification. A broader anatomical grouping was also used including distal vs proximal regions and right sided vs left sided tumors. Data were analyzed using T-test and chi-square test. Results: 118 (50.9%) male and 114 (49.1%) female patients were included in the study. Mean age was $57.3{\pm}14.7$ years, with 29.2% under 50 years. There was no significant gender difference for age at diagnosis. The rectum (56%) and sigmoid colon (25%) were the most frequent anatomical locations. Proximal cases accounted for 18.6% in males and 8.8% in females (p=0.02). AC was more prevalent than other usual types in younger patients. The proportion of proximal cancer was 1.7% in first eight years of the study period vs 12.1% in the second one (p=0.005). A similar trend was also seen in right sided colon cancers (p=0.018). Conclusions: Young people are also at risk for the cancer with poor prognosis. Screening programs and weight loss in obese individuals can reduce incidence and complications of CRC.

Keywords

References

  1. Ansari R, Mahdavinia M, Sadjadi A, et al (2006). Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett, 240, 143-7. https://doi.org/10.1016/j.canlet.2005.09.004
  2. Azadeh S, Moghimi-Dehkordi B, Fatem SR, et al (2008). Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
  3. Bafandeh Y, Khoshbaten M, Eftekhar-Sadat AT, Farhang S (2007). Colorectal neoplasms in symptomatic patients without evidence of bleeding: a prospective study in an Iranian population. Asian Pac J Cancer Prev, 8, 485-8.
  4. Esmailzadehha N, Ziaee A, Kazemifar AM, Ghorbani A, Oveisi S (2013). Prevalence of metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran: A comparative analysis of six definitions. Endocr Regul, 47, 111-20. https://doi.org/10.4149/endo_2013_03_111
  5. Fazeli MS, Adel MG, Lebaschi AH (2007). Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University. Dis Colon Rectum, 50, 990-5. https://doi.org/10.1007/s10350-007-0248-z
  6. Forootan M, Tabatabaeefar M, Yahyaei M, Maghsoodi N (2012). Metabolic syndrome and colorectal cancer: a cross-sectional survey. Asian Pac J Cancer Prev, 13, 4999-5002. https://doi.org/10.7314/APJCP.2012.13.10.4999
  7. Haghdoost AA, Chamani G, Zarei MR, Rad M, Heshmatpoor M, Marzban M(2011). Low Incidence of Colorectal Cancer in Kerman Province, Iran. Iran J Cancer Prev, 4, 33-7.
  8. Hosseini SV, Izadpanah A, Yarmohammadi H (2004). Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg, 74, 547-9. https://doi.org/10.1111/j.1445-2197.2004.03064.x
  9. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  10. Kaneko R, Sato Y, An Y, et al (2010). Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma. Asian Pac J Cancer Prev, 11, 975-83.
  11. Kang H, O'Connell JB, Maggard MA, Sack J, Ko CY (2005). A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum, 48, 1161-8. https://doi.org/10.1007/s10350-004-0932-1
  12. Khuhaprema T, Srivatanakul P (2008). Colon and rectum cancer in Thailand: an overview. Jpn J Clin Oncol, 38, 237-43. https://doi.org/10.1093/jjco/hyn020
  13. Kolahdoozan S, Sadjadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
  14. Larijani B, Maleckzadeh H, Pazhouhi M, et al (2003). Prevalence of Diabetes Mellitus & Impaired Glucose Tolerance of Population Aged Over 25 in Qazvin. Qazvin Univ of Med Sci, 26, 41.
  15. Mahaki B, Mehrabi Y, Kavousi A, et al (2011). Multivariate disease mapping of seven prevalent cancers in Iran using a shared component model. Asian Pac J Cancer Prev, 12, 2353-8.
  16. Mahdavinia M, Bishehsari F, Ansari R, et al (2005). Malekzadeh R. Family history of colorectal cancer in Iran. BMC Cancer, 5, 112. https://doi.org/10.1186/1471-2407-5-112
  17. Makino T, Tsujinaka T, Mishima H, et al(2006). Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases. Hepatogastroenterology, 53, 845-9.
  18. Maksimovic S (2007). Survival rates of patients with mucinous adenocarcinoma of the colorectum. Med Arh, 61, 26-9.
  19. Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R (2009). Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med, 12, 161-9.
  20. Mirzazadeh A, Sadeghirad B, Haghdoost AA, Bahrein F, Rezazadeh Kermani M (2009). The Prevalence of Obesity in Iran in Recent Decade; a Systematic Review and Meta-Analysis Study. Iranian J Publ Health, 38, 1-11
  21. Moghimi-Dehkordi B, Safaee A, Zali MR (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis, 23, 683-8. https://doi.org/10.1007/s00384-008-0463-7
  22. Moradi A, Khayamzadeh M, Guya M M, et al (2009). Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev, 10, 583-6.
  23. Omranipour R, Doroudian R, Mahmoodzadeh H (2012). Anatomical distribution of colorectal carcinoma in Iran: a retrospective 15-yr study to evaluate rightward shift. Asian Pac J Cancer Prev, 13, 279-82. https://doi.org/10.7314/APJCP.2012.13.1.279
  24. Rashid MR, Aziz AF, Ahmad S, Shah SA, Sagap I (2009). Colorectal cancer patients in a tertiary referral centre in Malaysia: a five year follow-up review. Asian Pac J Cancer Prev, 10, 1163-6.
  25. Redstone Mark, Odze RD (2009). Epithelial neoplasm of the large intestine. In: Odze RD, Goldblum JR, editors. Surgical pathology of GI tract, liver, biliary tract and pancreas. 2nd edition, Sunders-Elsevier, 598-615.
  26. Sadjadi A, Nooraie M, Ghorbani A, et al (2007).The incidence of prostate cancer in Iran: results of a population-based cancer registry. Arch Iran Med, 10, 481-5.
  27. Safaee A, Fatemi SR, Ashtari S, et al (2012). Four years incidence rate of colorectal cancer in Iran: a survey of national cancer registry data - implications for screening. Asian Pac J Cancer Prev, 13, 2695-8. https://doi.org/10.7314/APJCP.2012.13.6.2695
  28. SEER Training Website. Retrieved December 8, 2006 from http://training.seer.cancer.gov/.
  29. Shaikh AJ, Raza S, Shaikh AA, et al (2009). Demographics, pathologic patterns and long-term survival in operable colon cancers: local experience in Pakistan. Asian Pac J Cancer Prev, 10, 361-4.
  30. Song W, Wu SJ, He YL, et al (2009). Clinicopathologic features and survival of patients with colorectal mucinous, signetring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chin Med J, 122, 1486-91.
  31. Stewart SL, Wike JM, Kato I, Lewis DR, Michaud F (2006). A population-based study of colorectal cancer histology in the United States, 1998-2001. Cancer, 107, 1128-41. https://doi.org/10.1002/cncr.22010
  32. Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H (2009). Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol, 39, 189-91.

Cited by

  1. Descriptive Epidemiology of Colorectal Cancer in University Malaya Medical Centre, 2001 to 2010 vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6059
  2. Quality of Life and Psychological Well-Being of Colorectal Cancer Survivors in Jordan vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7653
  3. Histopathological Features of Colorectal Cancer in Al-Madinah Region of Saudi Arabia: 8 Years Experience vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.3133
  4. MiR-133b Acts as a Tumor Suppressor and Negatively Regulates TBPL1 in Colorectal Cancer Cells vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3767
  5. Demographic Survey of Four Thousand Patients with 10 Common Cancers in North Eastern Iran over the Past Three Decades vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10193
  6. Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman - a Single Center Study vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4853
  7. Spatiotemporal Distribution of Gastrointestinal Tract Cancer through GIS over 2007-2012 in Kermanshah-Iran vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7737
  8. Is there a proximal shift in the distribution of colorectal adenomas? vol.3, pp.4, 2015, https://doi.org/10.1177/2050640615577534
  9. Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II Colorectal Cancer Patients vol.2016, pp.1687-8469, 2016, https://doi.org/10.1155/2016/2196703